What does CUSIP 23254L405 represent in this 13F holders report?

CUSIP 23254L405 is the security identifier for CYCC - CYCLACEL PHARMACEUTICALS INC - COM PAR used to aggregate holder disclosures.

How many institutions held CYCC - CYCLACEL PHARMACEUTICALS INC - COM PAR in Q4 2019?

11 institutional investors reported CYCC - CYCLACEL PHARMACEUTICALS INC - COM PAR for Q4 2019. Use the holders table for investor-level position and value details.

CYCLACEL PHARMACEUTICALS INC - COM PAR (CYCC)

CUSIP: 23254L405

Q4 2019 13F Holders as of 31 Dec 2019

Security type / class: Equity / COM PAR
Total 13F shares: 1,630,367
Total 13F value: $1,092,143
Share change: +104,382
SEC-reported price per share: $0.67
Number of holders: 11
Value change: +$71,567
Number of buys: 4
Number of sells: 3

Security key

23254L405

Report period

Q4 2019

Institutions

Top holders

CYCC full security history Ownership snapshot Full 13F holder table Bio Green Med Solution, Inc. SEC filings Bio Green Med Solution, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of CYCC - CYCLACEL PHARMACEUTICALS INC - COM PAR (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

RENAISSANCE TECHNOLOGIES LLC

Disclosed value leader

RENAISSANCE TECHNOLOGIES LLC

Comparable rows

0/11

Latest evidence

30 Sep 2019

13F Highest disclosed value: $464,000 11 rows are not safely comparable across share classes. Showing 1-6 of 11 holder rows.

Quick read

RENAISSANCE TECHNOLOGIES LLC has the largest disclosed position value at $464K.

0 of 11 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RENAISSANCE TECHNOLOGIES LLC's linked filing trail.

Disclosed position value Top 5

RENAISSANCE TECHNOLOGIES LLC $464K

VANGUARD GROUP INC $42K

GEODE CAPITAL MANAGEMENT, LLC $32K

Raymond James Financial Services ... $30K

UBS Group AG $30K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 11 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
RENAISSANCE TECHNOLOGIES LLC	13F Company 13F	— denominator unverified	$464,000 1,170,962 shares	—	30 Sep 2019
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$42,000 106,172 shares	—	30 Sep 2019
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	— denominator unverified	$32,000 81,343 shares	—	30 Sep 2019
Raymond James Financial Services Advisors, Inc.	13F Company 13F	— denominator unverified	$30,000 75,125 shares	—	30 Sep 2019
UBS Group AG	13F Company 13F	— mixed-class rows	$30,000 28,808 shares mixed-class rows	—	30 Sep 2019
Virtu Financial LLC	13F Company 13F	— denominator unverified	$10,000 26,402 shares	—	30 Sep 2019

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2019

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

1,630,367

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2019 vs Q3 2019 Across Filers

Q3 2019 holders

Q4 2019 holders

Holder diff

Investor	Q3 2019 Shares	Q4 2019 Shares	Share Diff	Share Chg %	Q3 2019 value	Q4 2019 value	Value change	Value Chg %